Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06663696

CRUZ Tunisia-Multivessel Registry

Sponsor: Sahajanand Medical Technologies Limited

View on ClinicalTrials.gov

Summary

The primary objective of this registry is to evaluate the safety and clinical performance of the biodegradable polymer-coated Supraflex Cruz Sirolimus-eluting Stent (SES) in an unselected, all-comer patient population with multivessel disease. This population represents daily clinical practice and includes patients requiring coronary revascularization with drug-eluting stents (DES).

Official title: Evaluation of the Safety and Clinical Performance of the Biodegradable Polymer-Coated Sirolimus-Eluting Stent in All-Comer Patients With Multivessel Coronary Artery Disease

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2024-11-01

Completion Date

2028-05

Last Updated

2025-02-19

Healthy Volunteers

No

Interventions

DEVICE

Supraflex Cruz Sirolimus-eluting Coronary Stent System

Biodegradable polymer-coated, cobalt-chromium sirolimus-eluting coronary stent

Locations (2)

Sahloul Hospital

Sousse, Tunisia

Habib Thameur Hospital

Tunis, Tunisia